TEVA 22 10 (Sucralfate 1 g)
Pill imprint TEVA 22 10 has been identified as Sucralfate 1 g.
Sucralfate is used in the treatment of gerd; stomach ulcer; duodenal ulcer; hyperphosphatemia of renal failure; stomatitis (and more), and belongs to the drug class miscellaneous GI agents. There is no proven risk in humans during pregnancy. Sucralfate 1 g is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about sucralfate
- Other brands: Carafate
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.